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Should we go nuts about nuts?
Sabine Rohrmann* and David Faeh
Abstract
Since the beginning of the 1990s, increasing evidence supports beneficial effects of nut consumption on health. A
new analysis of the Spanish PREDIMED trial, published in BMC Medicine, has expanded our knowledge. The study
showed that individuals eating nuts more than three times per week died less often from cardiovascular disease
and cancer than non-consumers. The study also adds an important finding that previous epidemiological studies
could not provide: a protective effect on premature mortality was only seen in the intervention group in which nut
consumption increased during the 4.8 years of follow-up, not in the intervention group with additional olive oil
consumption or in the control group. Nut consumption actually decreased during follow-up in the latter two
groups. Questions remain to be answered on the quantity of nuts to be consumed for health benefits, on possible
mechanisms of action, and on whether some types of nuts should be favored.
Please see related research: http://www.biomedcentral.com/1741-7015/11/164.
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Background
More than 20 years ago, the first studies were published
on possible favorable effects of nut consumption on health
in the general population [1,2]. Since then, the effects of
nut consumption on health have been examined inten-
sively. Nut consumption improves the body’s lipid profile
and may influence inflammatory processes, oxidative
stress, vascular reactivity and glycemic control [3]. The
study by Guasch-Ferré et al. published in BMC Medicine
which used information of the dietary intervention trial
PREDIMED [4], provides additional convincing support
for protective effects on cardiovascular disease and cancer
mortality. Still, some questions remain open.
Study results
Guasch-Ferré et al. [4] examined the association between
consumption of almonds, peanuts, hazelnuts, pistachios,
pine nuts and walnuts (as a separate group) and mortality
in the PREDIMED nutrition intervention trials. The current
analysis of the PREDIMED study included 7,216 individuals
with increased cardiovascular risk [4]. Compared to
never consumers of nuts at baseline, a decreased over-
all mortality was seen in those who consumed one to
three servings (one serving = 28 g of nuts) per week
(hazard ratio (HR) = 0.71, 95% confidence interval (CI)
0.54 to 0.83) and those who consumed three or more
servings per week (HR = 0.61, 95% CI 0.54 to 0.93). An
effect on overall mortality was observed for walnuts and
‘other types of nuts’. The effect was similar for cardiovas-
cular mortality, whereas for cancer mortality an inverse
association was observed only in those eating three or
more servings and only for walnuts.
Future directions
In 2003, a qualified health claim was approved by the
U.S. Food and Drug Administration for nuts and cardio-
vascular disease, which states that ‘Scientific evidence
suggests but does not prove that eating 1.5 ounces (42 g)
per day of most nuts, as part of a diet low in saturated fat
and cholesterol, may reduce the risk of heart disease.’
The European Union added in 2012 ‘Walnuts contribute
to the improvement of the elasticity of the blood vessels.’
The claim may be used only for food that provides a daily
intake of 30 g of walnuts. So, do we need any more
evidence that nuts are good for health?
Isn't it all just due to the Mediterranean diet?
Although nuts are consumed by about 75% of the European
population [5], the average daily consumption is small
and follows a north to south gradient (0.4 g/day in the
north and 1.7 g/day in the south [6]). Therefore, based
on the PREDIMED study, one may simply conclude
that protection rather comes from a general adherence
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to the Mediterranean diet than from isolated nut con-
sumption. However, so far, most evidence suggesting
that nut consumption may protect from cardiovascular
and other chronic diseases comes from the US [3]. In
the US, nut consumption is generally as low as in middle
and northern European countries and there is only a weak
adherence to the Mediterranean diet [7]. Nut consumption
improves nutrient intake and diet quality [7]; thus, further
evidence for an effect of nut consumption in addition to
a generally healthy diet is warranted. Just recently [8],
the PREDIMED trial showed that a Mediterranean diet
supplemented with olive oil or nuts reduced the incidence
of cardiovascular disease compared with a control diet in
which the participants were told to reduce dietary fat in-
take. However, neither intervention significantly decreased
all-cause or cardiovascular mortality, which were secondary
outcomes of the PREDIMED trial. Thus, the current
analysis of the PREDIMED data speaks in favor of an
additional protective effect of nut consumption in the
framework of a healthy diet [4,8].
Are walnuts particularly healthy?
The results of this study have shown an effect of any nut
consumption on all outcomes [4]. However, although
reduced all-cause and cardiovascular disease mortality
were observed among consumers of walnuts and ‘other
nuts’, cancer mortality was only inversely associated with
the consumption of walnuts. Nuts are rich in polyunsatur-
ated fatty acids, but also in minerals (calcium, magnesium,
potassium) and vitamins. Additionally, they contain a num-
ber of phytochemicals such as phenolic acids, polyphenols
and phytosterols [3,9]. Compared to other nuts, walnuts
have a particularly high content of alpha-linolenic acid,
and possibly also a higher bioavailability of the above-
mentioned phytochemicals [10]: walnuts are usually
consumed with the ‘skin’, which has the highest content
of phytochemicals, whereas this skin is usually removed
from other nuts before consumption. Thus, it has been
speculated that walnuts might have stronger health ef-
fects than other types of nuts. This is however in con-
trast to other results, for example, from a meta-analysis
showing that different types of nuts had similar effects
on blood lipid levels [11]. So far, evidence is lacking for
advice concerning a specific type of nut in addition to
general nut consumption.
Health effects of nuts: do changes over time and overall
duration of consumption matter?
Looking merely at the overall results of this study, there
is a strong inverse association between baseline nut con-
sumption and mortality. Looking more in depth shows
that the dietary behavior during the follow-up period
was important for the observed effects [4]. In fact, after
disentangling the three arms, the association was only
statistically significant in the arm with the nuts interven-
tion (HR = 0.37, 95% CI 0.22 to 0.66), not in the olive oil
intervention arm (HR = 0.63, 95% CI 0.36 to 1.10) or in
the control arm (HR = 0.84, 95% CI 0.48 to 1.44). In
this respect, it is interesting to note the changes in nut
consumption in the three groups: participants in the
Mediterranean diet arm with additional nuts increased
their nut consumption by about 16 g/day. By contrast,
consumption decreased by 0.8 g/day in the Mediterranean
diet arm with olive oil and by 3.1 g/day in the control
arm. To further clarify the question of changes in con-
sumption over time in the context of other dietary
properties, further research is required. It will, for ex-
ample, be interesting to learn more about the impact
of timing and duration of nut consumption on cancer
incidence given that some types of cancer develop with
a latency of decades.
What amount has to be consumed to provide
health benefits?
Guasch-Ferré et al. observed an effect in a Mediterranean
country [4], where nut consumption is usually higher
than in other Western countries [6]. An overall pro-
tective effect was observed for those consuming at
least one to three servings per week, which translates
to approximately 4 to 12 g/day; for cancer, the effect
was observed only among those who consumed three
or more servings per week. This is in line with results
from other studies [12,13]. In an Australian study [14],
a statistically significant reduction in death due to inflam-
matory causes was observed for as little as 1.4 g/day com-
pared with < 0.9 g/day. However, this leads to one of the
crucial questions in nutrition epidemiology: how validly
can nut consumption be assessed and monitored in large
epidemiological studies? The question of how many nuts
do we need to eat for how long to prevent x, y and z may
best be addressed in intervention studies, in which con-
sumption can be better controlled and assessed than in
observational studies.
Conclusion
The analysis by Guasch-Ferré and colleagues contributes
further evidence that nut consumption is good for health
and may prevent premature deaths. Questions about
specific constituents, amount, duration and type of nuts
to be consumed remain to be elucidated. Meanwhile,
we might need to focus on the question of how to bet-
ter promote nut consumption in the population and
sustainably integrate it into the daily diet. Currently,
several dietary guidelines recommend replacing one of
five servings of fruits and vegetables a day by a serving
of nuts. This appears to be a simple and practical rec-
ommendation to start with.
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